TD Asset Management
GOSS icon

TD Asset Management’s Gossamer Bio GOSS Stock Holding History

TD Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-916,250
Closed -$880K – 1320
2024
Q3 		$880K Buy
916,250
+274,752
+43% +$264K ﹤0.01% 1213
2024
Q2 		$578K Buy
641,498
+219,238
+52% +$164K ﹤0.01% 1250
2024
Q1 		$498K Sell
422,260
-82,540
-16% -$90.9K ﹤0.01% 1297
2023
Q4 		$461K Buy
+504,800
New +$373K ﹤0.01% 1311
2023
Q3 		– Sell
-95,100
Closed -$114K – 1425
2023
Q2 		$114K Buy
95,100
+69,433
+271% +$86.5K ﹤0.01% 1386
2023
Q1 		$32.3K Sell
25,667
-8,133
-24% -$15.6K ﹤0.01% 1409
2022
Q4 		$73.3K Buy
+33,800
New +$278K ﹤0.01% 1417

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

TD Asset Management's GOSS Position: Q4 2024 in Review

TD Asset Management sold out of Gossamer Bio (GOSS) in Q4 2024, closing a stake of 916,250 shares — an estimated $880K sold.

TD Asset Management first reported a position in GOSS in Q4 2022 and held it in 7 quarters. The position peaked at $880K in Q3 2024. 105 funds tracked by Wall St. Rank hold GOSS as of Q4 2024.

  • TD Asset Management reported no remaining Gossamer Bio position as of Q4 2024 after selling out during the quarter.
  • TD Asset Management sold 916,250 Gossamer Bio shares in Q4 2024, an estimated $880K.
  • TD Asset Management first reported a position in Gossamer Bio in Q4 2022 and held it in 7 quarters.
  • TD Asset Management's Gossamer Bio position peaked at $880K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2024.

Based on TD Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.